Volume 26, Number 4—April 2020
Dispatch
Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017
Kerstin Fischer, Roland Suluku, Sarah Katharina Fehling, Juliet Jabaty, Bashiru Koroma, Thomas Strecker, Martin H. Groschup, and Sandra Diederich
Table 1
EBOV-specific antibodies detected in dog serum samples, by dog age, collected in Moyamba District, Sierra Leone, October–December 2017*
| Age, mo. |
No. samples tested |
EBOV-NP ELISA, no. (%) reactive |
Confirmatory EBOV-NP WB, no. (%) reactive |
EBOV VNT |
|
|---|---|---|---|---|---|
| No. (%) positive |
Titers |
||||
| <12 | 27 | 2 (7.4) | 0 | 0 | NA |
| 12 –18 | 60 | 7 (11.7) | 6 (10.0) | 5 (8.3) | 1:11, 1:11, 1:13, 1:16, 1:27 |
| 19–24 | 50 | 4 (8.0) | 3 (6.0) | 1 (2.0) | 1:11 |
| 25–36 | 90 | 11 (12.2) | 5 (5.6) | 4 (4.4) | 1:16, 1:16, 1:19, 1:32 |
| 37–48 | 39 | 7 (17.9) | 5 (12.8) | 5 (12.8) | 1:11, 1:16, 1:19, 1:23,1:45 |
| >48 |
34 |
5 (14.7) |
1 (2.9) |
3 (8.8) |
1:11, 1:19, 1:19 |
| Total | 300 | 36 (12.0) | 20 (6.7) | 18 (6.0) | |
*EBOV, Ebola virus; NA, not applicable; NP, nucleoprotein; VNT, virus neutralization test; WB, Western blot.
Page created: March 17, 2020
Page updated: March 17, 2020
Page reviewed: March 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.